Activin and Inhibin

ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 ( aldh1a1 ). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsForm:SolidIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsForm:SolidIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsForm:SolidIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsForm:SolidIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsForm:SolidIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A2-IN-1 is an active site-directed reversible ALDH1A2 inhibitor ( IC 50 =0.91 μM: Kd =0.26 μM) with several hydrophobic interactionsIC50&amp: Target:IC50: 0.91 μM (ALDH1A2), Kd: 0.26 μM (ALDH1A2).

ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC 50 of 0.63 µM and a K i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancerIn VitroALDH1A3-IN-1 (Compound 14) (0-200 µM, 96 h) shows antiproliferative activity in prostate

ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC 50 of 0.63 µM and a K i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancerIn VitroALDH1A3-IN-1 (Compound 14) (0-200 µM, 96 h) shows antiproliferative activity in prostate

ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC 50 of 0.63 µM and a K i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancerIn VitroALDH1A3-IN-1 (Compound 14) (0-200 µM, 96 h) shows antiproliferative activity in prostate

ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC 50 of 0.63 µM and a K i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancerIn VitroALDH1A3-IN-1 (Compound 14) (0-200 µM, 96 h) shows antiproliferative activity in prostate

ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC 50 of 0.63 µM and a K i of 0.46 µM. ALDH1A3-IN-1 can be studied in prostate cancerIn VitroALDH1A3-IN-1 (Compound 14) (0-200 µM, 96 h) shows antiproliferative activity in prostate